A phase II study of talazoparib and avelumab in VHL deficient clear cell renal cell carcinoma Meeting Abstract
| Authors: | Kotecha, R.; Lee, C. H.; McHugh, D. J.; Dadoun, C.; Knezevic, A.; Carlo, M. I.; Feld, E.; Shapnik, N.; Shah, N. J.; Feldman, D. R.; Motzer, R. J.; Voss, M. H. |
| Abstract Title: | A phase II study of talazoparib and avelumab in VHL deficient clear cell renal cell carcinoma |
| Meeting Title: | 2022 ASCO Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2022 Feb 17-19 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-02-20 |
| Language: | English |
| ACCESSION: | WOS:000771008900351 |
| DOI: | 10.1200/JCO.2022.40.6_suppl.347 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 347 -- Meeting was conducted online as well as in person -- Source: Wos |
